benzylideneacetone profile

benzylideneacetone: RN given refers to cpd without isomeric; structure in Merck Index, 9th ed, #1153 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

trans-benzylideneacetone : The trans-isomer of benzylideneacetone. It acts as an inhibitor of the enzyme phospholipase A2 (EC 3.1.1.4) of insects like diamond back moth. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

benzylideneacetone : An enone in which a phenyl ring is attached to the beta-carbon atom of but-3-en-2-one. Although both cis- and trans-isomers are possible for the alpha,beta-unsaturated ketone, only the trans-isomer is observed. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID Source	ID
PubMed CID	637759
CHEMBL ID	73639
CHEBI ID	78399
CHEBI ID	217301
SCHEMBL ID	76632
SCHEMBL ID	312972
MeSH ID	M0084647

Synonyms (134)

Synonym
CHEMBL73639
chebi:78399 ,
4-07-00-01003 (beilstein handbook reference)
b03x40bmt5 ,
unii-b03x40bmt5
LS-13761
3-buten-2-one, 4-phenyl-
nsc5605
4-phenylbutenone
4-phenyl-3-buten-2-one
acetocinnamone
methyl styryl ketone
wln: 1v1u1r
styryl methyl ketone
benzalacetone
2-phenylvinyl methyl ketone
methyl .beta.-styryl ketone
benzylidene acetone
benzalaceton
122-57-6
benzylideneacetone
nsc-5605
trans-benzalacetone
3-buten-2-one, 4-phenyl-, (e)-
NCGC00091356-01
trans-benzylidenacetone
trans-4-phenyl-3-butene-2-one
einecs 204-555-1
ketone, methyl styryl
methyl beta-styryl ketone
benzilidene acetone
trans-4-phenylbut-3-en-2-one
ai3-00944
brn 0742046
brn 0742047
benzalaceton [german]
benzylidene acetone (natural)
fema no. 2881
einecs 217-587-6
tpbo
trans-benzylideneacetone
methyl 2-phenylvinyl ketone
nsc 5605
benzilideneacetone
ccris 5319
ai3-52291
4-phenyl-3-butene-2-one
inchi=1/c10h10o/c1-9(11)7-8-10-5-3-2-4-6-10/h2-8h,1h3/b8-7
3-buten,2-one,4-phenyl (trans) benzalacetone
GHL.PD_MITSCHER_LEG0.147 ,
benzylideneacetone, >=98%, fg
trans-4-phenyl-3-buten-2-one, >=99%
4-phenyl-3-buten-2-one, 99%
(3e)-4-phenylbut-3-en-2-one
1896-62-4
methyl styryl acetone
methyl trans-styryl ketone
benzylideneacetone, (z)-isomer
trans-4-phenyl-3-buten-2-one
t-pbo
benzylideneacetone, (e)-isomer
smr001252234
MLS002454416
P0163
STK803195
benz
CHEBI:217301 ,
4-phenylbut-3-en-2-one
(e)-4-phenylbut-3-en-2-one
AKOS000119902
A804921
NCGC00091356-02
ec 204-555-1
2-07-00-00287 (beilstein handbook reference)
NCGC00257166-01
dtxsid1031626 ,
cas-1896-62-4
cas-122-57-6
dtxcid305662
tox21_303222
dtxcid9011626
NCGC00255323-01
tox21_301598
dtxsid4025662 ,
NCGC00259053-01
tox21_201502
A813340
(e)-4-phenyl-3-buten-2-one
(e)-4-phenyl-but-3-en-2-one
HMS2268K18
S9478
(3e)-4-phenyl-3-buten-2-one
EPITOPE ID:120383
benzylideneacetone [mi]
(3e)-4-phenylbut-3-en-2-one (benzalacetone)
4-phenyl-3-buten-2-one [fhfi]
warfarin sodium impurity c [ep impurity]
4-phenyl-3-buten-2-one, trans
benzylideneacetone, (e)-
benzalacetone [usp impurity]
cinnamyl methyl ketone
3-buten-2-one, 4-phenyl-, (3e)-
benzalacetone-d4
SCHEMBL76632
SCHEMBL312972
e-4-phenyl-3-buten-2-one
4-phenyl-but-3-en-2-one
(e)-1-buten-3-one, 1-phenyl
W-107746
1-buten-3-one-1-phenyl
1-phenyl-1-buten-3-one
W-109036
benzalacetone, analytical standard
F0001-0357
mfcd00008779
fema 2881
trans-4-phenyl-but-3-en-2-one
(3e)-4-phenylbut-3-en-2-one; warfarin sodium imp. c (ep); benzalacetone; warfarin sodium impurity c; warfarin impurity c
benzalaceton (german)
4-phenyl-(e)-3-buten-2-one
3-buten,2-one,4-phenyl (trans) benzalacetone
methyl beta -styryl ketone
CS-W013311
DS-4780
Q4380955
EN300-18891
AMY6963
benzylidenacetone
trans-benzylideneacetone;benzalacetone
D70186
D70528
HY-W012595
EN300-366968
Z2582847786

Role	Description
flavouring agent	A food additive that is used to added improve the taste or odour of a food.
fragrance	A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell.
bacterial metabolite	Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
EC 3.1.1.4 (phospholipase A2) inhibitor	An EC 3.1.1.* (carboxylic ester hydrolase) inhibitor that interferes with the action of phospholipase A2 (EC 3.1.1.4).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Class	Description
benzylideneacetone	An enone in which a phenyl ring is attached to the beta-carbon atom of but-3-en-2-one. Although both cis- and trans-isomers are possible for the alpha,beta-unsaturated ketone, only the trans-isomer is observed.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (19)

Potency Measurements

Protein	Taxonomy	Measurement	Average (µ)	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Chain A, TYROSYL-DNA PHOSPHODIESTERASE	Homo sapiens (human)	Potency	19.9526	0.0040	23.8416	100.0000	AID485290
RAR-related orphan receptor gamma	Mus musculus (house mouse)	Potency	68.5896	0.0060	38.0041	19,952.5996	AID1159521
ATAD5 protein, partial	Homo sapiens (human)	Potency	11.5774	0.0041	10.8903	31.5287	AID504467
AR protein	Homo sapiens (human)	Potency	75.5522	0.0002	21.2231	8,912.5098	AID1259243
glucocorticoid receptor [Homo sapiens]	Homo sapiens (human)	Potency	0.2239	0.0002	14.3764	60.0339	AID588532
retinoic acid nuclear receptor alpha variant 1	Homo sapiens (human)	Potency	75.5522	0.0030	41.6115	22,387.1992	AID1159552
retinoid X nuclear receptor alpha	Homo sapiens (human)	Potency	42.8711	0.0008	17.5051	59.3239	AID1159527; AID1159531
estrogen-related nuclear receptor alpha	Homo sapiens (human)	Potency	95.1146	0.0015	30.6073	15,848.9004	AID1224841
pregnane X nuclear receptor	Homo sapiens (human)	Potency	76.9588	0.0054	28.0263	1,258.9301	AID1346982
estrogen nuclear receptor alpha	Homo sapiens (human)	Potency	15.4034	0.0002	29.3054	16,493.5996	AID743075; AID743079
alpha-galactosidase	Homo sapiens (human)	Potency	7.0795	4.4668	18.3916	35.4813	AID2107
thyroid stimulating hormone receptor	Homo sapiens (human)	Potency	67.3360	0.0016	28.0151	77.1139	AID1259385
chromobox protein homolog 1	Homo sapiens (human)	Potency	100.0000	0.0060	26.1688	89.1251	AID540317
heat shock protein beta-1	Homo sapiens (human)	Potency	55.3055	0.0420	27.3789	61.6448	AID743210
nuclear factor erythroid 2-related factor 2 isoform 1	Homo sapiens (human)	Potency	55.9333	0.0006	27.2152	1,122.0200	AID743202
Guanine nucleotide-binding protein G	Homo sapiens (human)	Potency	28.1838	1.9953	25.5327	50.1187	AID624287
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

Protein	Taxonomy	Measurement	Average	Min (ref.)	Avg (ref.)	Max (ref.)	Bioassay(s)
Substance-P receptor	Cavia porcellus (domestic guinea pig)	CD	15.0000	0.9000	4.5000	9.8000	AID144377
Quinone oxidoreductase	Mus musculus (house mouse)	CD	15.0000	0.2000	2.7421	9.8000	AID144377
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (5)

Process	via Protein(s)	Taxonomy
negative regulation of inflammatory response to antigenic stimulus	Guanine nucleotide-binding protein G	Homo sapiens (human)
renal water homeostasis	Guanine nucleotide-binding protein G	Homo sapiens (human)
G protein-coupled receptor signaling pathway	Guanine nucleotide-binding protein G	Homo sapiens (human)
regulation of insulin secretion	Guanine nucleotide-binding protein G	Homo sapiens (human)
cellular response to glucagon stimulus	Guanine nucleotide-binding protein G	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (2)

Process	via Protein(s)	Taxonomy
G protein activity	Guanine nucleotide-binding protein G	Homo sapiens (human)
adenylate cyclase activator activity	Guanine nucleotide-binding protein G	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (1)

Process	via Protein(s)	Taxonomy
plasma membrane	Guanine nucleotide-binding protein G	Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay ID	Title	Year	Journal	Article
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635	Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812	Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845	Primary qHTS for Inhibitors of ATXN expression
AID1347082	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Current protocols in cytometry, Oct, Volume: Chapter 13	Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2006	Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5	Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501	High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set	2010	Assay and drug development technologies, Feb, Volume: 8, Issue:1	High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID504810	Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign	2010	Endocrinology, Jul, Volume: 151, Issue:7	A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347083	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086	qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal	2020	Antiviral research, 01, Volume: 173	A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID440586	Acute toxicity in rat	2009	European journal of medicinal chemistry, Dec, Volume: 44, Issue:12	Analgesic, anticonvulsant and anti-inflammatory activities of some synthesized benzodiazipine, triazolopyrimidine and bis-imide derivatives.
AID1810347	Glutathione reactivity at pH 7.4 assessed as glutathione-conjugated products measured after 4 hrs by LC-MS/MS method	2021	Journal of medicinal chemistry, 05-27, Volume: 64, Issue:10	Synthesis and Evaluation of PPARδ Agonists That Promote Osteogenesis in a Human Mesenchymal Stem Cell Culture and in a Mouse Model of Human Osteoporosis.
AID144377	Ability to induce NAD(P)H quinone reductase activity in cultured Hepa 1c1c7 murine hepatoma cells.	1998	Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26	Chemoprotective properties of phenylpropenoids, bis(benzylidene)cycloalkanones, and related Michael reaction acceptors: correlation of potencies as phase 2 enzyme inducers and radical scavengers.
AID426106	Antiproliferative activity against human HeLa cells after 72 hrs by trypan blue assay	2009	European journal of medicinal chemistry, Jul, Volume: 44, Issue:7	DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
AID1092125	Inhibition of phenoloxidase activity in hemolymph of Spodoptera exigua fifth-instar larvae using DOPA substrate	2012	Applied and environmental microbiology, Jun, Volume: 78, Issue:11	Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID379150	Cytotoxicity against human KB cells after 2 days by sulforhodamine B assay	2006	Journal of natural products, Oct, Volume: 69, Issue:10	Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
AID1092126	Inhibition of PLA2 in hemocytes of Spodoptera exigua fifth-instar larvae using pyrene-labeled phospholipid substrate by spectrofluorometry	2012	Applied and environmental microbiology, Jun, Volume: 78, Issue:11	Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID379151	Cytotoxicity against multidrug-resistant human KB-VCR cells after 2 days by sulforhodamine B assay	2006	Journal of natural products, Oct, Volume: 69, Issue:10	Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
AID426108	Binding affinity to salmon testes DNA assessed as occurrence of intercalative molecular complex by linear flow dichroism	2009	European journal of medicinal chemistry, Jul, Volume: 44, Issue:7	DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
AID1092122	Potentiation of 1000 ppm Bacillus thuringiensis-induced pathogenicity against Plutella xylostella (diamondback moth) fourth-instar larvae at 10000 ppm measured 48 hr post compound treatment	2012	Applied and environmental microbiology, Jun, Volume: 78, Issue:11	Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID426105	Antiproliferative activity against human HL60 cells after 72 hrs by trypan blue assay	2009	European journal of medicinal chemistry, Jul, Volume: 44, Issue:7	DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
AID1092123	Insecticidal activity against Plutella xylostella (diamondback moth) fourth-instar larvae fed on cabbage leaves soaked in compound solutions measured 48 hr post compound treatment by leaf-dipping method	2012	Applied and environmental microbiology, Jun, Volume: 78, Issue:11	Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID1092124	Inhibition of immune responses in Spodoptera exigua fifth-instar larvae assessed as inhibition of hemocytic nodulation in response to Escherichia coli challenge by stereomicroscopy	2012	Applied and environmental microbiology, Jun, Volume: 78, Issue:11	Phospholipase A2 inhibitors synthesized by two entomopathogenic bacteria, Xenorhabdus nematophila and Photorhabdus temperata subsp. temperata.
AID379152	Cytotoxicity against human A549 cells after 2 days by sulforhodamine B assay	2006	Journal of natural products, Oct, Volume: 69, Issue:10	Dehydrozingerone, chalcone, and isoeugenol analogues as in vitro anticancer agents.
AID70871	Inhibition of UV-induced mutagenesis in Escherichia coli WP2uvrA	2002	Bioorganic & medicinal chemistry letters, Sep-02, Volume: 12, Issue:17	Quantum chemical- and 3-D-QSAR (CoMFA) studies of benzalacetones and 1,1,1-trifluoro-4-phenyl-3-buten-2-ones.
AID1269940	Cytotoxicity against human Raji cells expressing EBV-EA assessed as inhibition of TPA-induced EBV-EA activation after 48 hrs by trypan blue staining based immunofluorescence method relative to TPA	2016	Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue:4	An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG).
AID426107	Antiproliferative activity against human JR8 cells after 72 hrs by trypan blue assay	2009	European journal of medicinal chemistry, Jul, Volume: 44, Issue:7	DNA-targeting pyrroloquinoline-linked butenone and chalcones: synthesis and biological evaluation.
AID1167300	Antioxidant activity assessed as DPPH radical scavenging activity incubated at room temperature for 20 mins by UV-visible spectrophotometry	2014	Bioorganic & medicinal chemistry letters, Nov-01, Volume: 24, Issue:21	Design, synthesis and exploring the quantitative structure-activity relationship of some antioxidant flavonoid analogues.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	7 (9.86)	18.7374
1990's	12 (16.90)	18.2507
2000's	24 (33.80)	29.6817
2010's	22 (30.99)	24.3611
2020's	6 (8.45)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	1 (1.35%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	73 (98.65%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Condition	Relationship Strength	Studies
Acute Lung Injury	low	1
Age-Related Osteoporosis	low	1
Aging	low	1
Amyloid Deposits	low	1
Amyloid Plaques	low	1
Bone Loss, Age-Related	low	1
Cancer of Liver	low	1
Cancer of the Liver	low	1
Cancer, Hepatocellular	low	1
Carcinoma, Hepatocellular	low	1
Contact Dermatitis	low	1
Deficiency, Protein	low	1
Dermatitis Venenata	low	1
Dermatitis, Contact	low	1
Disease Models, Animal	low	2
Eczema, Contact	low	1
Experimental Hepatoma	low	1
Experimental Hepatomas	low	1
Experimental Liver Neoplasms	low	1
Experimental Lung Inflammation	low	1
Hepatic Cancer	low	1
Hepatic Neoplasms	low	1
Hepatocellular Cancer	low	1
Hepatocellular Carcinoma	low	1
Hepatoma	low	1
Hepatoma, Experimental	low	1
Hepatoma, Morris	low	1
Hepatoma, Novikoff	low	1
Hepatomas, Experimental	low	1
Herpes Simplex	low	1
Herpes Simplex Virus Infection	low	1
Hypersensitivity, Contact	low	1
Inflammation	low	1
Innate Inflammatory Response	low	1
Liver Cancer	low	1
Liver Cancer, Adult	low	1
Liver Cell Carcinoma	low	1
Liver Cell Carcinoma, Adult	low	1
Liver Neoplasms	low	1
Liver Neoplasms, Experimental	low	1
Lobar Pneumonia	low	1
Lung Inflammation	low	1
Lung Injury, Acute	low	1
Neoplasms, Experimental Liver	low	1
Neoplasms, Hepatic	low	1
Neoplasms, Liver	low	1
Neuritic Plaques	low	1
Osteoporosis	low	1
Osteoporosis, Age-Related	low	1
Osteoporosis, Involutional	low	1
Osteoporosis, Post-Traumatic	low	1
Osteoporosis, Senile	low	1
Plaque, Amyloid	low	1
Plaques, Amyloid	low	1
Pneumonia	low	1
Pneumonia, Lobar	low	1
Pneumonitis	low	1
Protein Deficiency	low	1
Pulmonary Inflammation	low	1
Senile Osteoporosis	low	1
Senile Plaques	low	1
Sensitivity, Contact	low	1

Article	Year
An appraisal on recent medicinal perspective of curcumin degradant: Dehydrozingerone (DZG). Bioorganic & medicinal chemistry, Feb-15, Volume: 24, Issue: 4	2016
Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice. Drug metabolism and disposition: the biological fate of chemicals, Volume: 25, Issue: 10	1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Article	Year
Toxicology and carcinogenesis studies of methyl trans-styryl ketone (CAS NO 1896-62-4) in F344/N rats and B6C3F1 mice (feed and dermal studies). National Toxicology Program technical report series, Issue: 572	2012
Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice. Drug metabolism and disposition: the biological fate of chemicals, Volume: 25, Issue: 10	1997
Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat. Drug metabolism and disposition: the biological fate of chemicals, Volume: 25, Issue: 6	1997
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

benzylideneacetone

Description

Cross-References

Synonyms (134)

Roles (4)

Drug Classes (1)

Protein Targets (19)

Potency Measurements

Inhibition Measurements

Other Measurements

Biological Processes (5)

Molecular Functions (2)

Ceullar Components (1)

Bioassays (34)

Research

Studies (71)

Study Types

Research Highlights

Bioavailability (2)

Dosage (3)

benzylideneacetone

Description

Cross-References

Synonyms (134)

Roles (4)

Drug Classes (1)

Protein Targets (19)

Potency Measurements

Inhibition Measurements

Other Measurements

Biological Processes (5)

Molecular Functions (2)

Ceullar Components (1)

Bioassays (34)

Research

Studies (71)

Study Types

Related Drugs (462)

Related Conditions (62)

Research Highlights

Bioavailability (2)

Dosage (3)